Skip to main content
Top
Published in: Inflammation 5/2020

01-10-2020 | Stroke | Original Article

KCNQ1OT1 Exacerbates Ischemia–Reperfusion Injury Through Targeted Inhibition of miR-140-3P

Authors: Ming Yi, Yue Li, Dan Wang, Qiuxia Zhang, Li Yang, Chunsheng Yang

Published in: Inflammation | Issue 5/2020

Login to get access

Abstract

Potassium voltage-gated channel subfamily Q member 1 opposite strand 1 (KCNQ1OT1), a long non-coding RNA found in the KCNQ1 locus, has been evidenced to play important roles in the aggravation of inflammatory and oxidative stresses under hypoxia, but whether and how KCNQ1OT1 contributes to neuronal damages in the cerebral ischemic stroke remains unknown. In the present study, we found a dominant upregulation of KCNQ1OT1 both in the plasma of cerebral ischemia patients and in an oxygen-glucose deprivation and reperfusion (OGD/R) model in PC12 cells. KCNQ1OT1 knocking-down significantly ameliorated the inflammation, oxidative stress, and cell apoptosis induced by OGD/R. We further demonstrated that KCNQ1OT1 directly bound to and suppressed the expression of miR-140-3p. Overexpressing miR-140-3p significantly alleviated both the inflammation, oxidative stress, and cell apoptosis in OGD/R, while all those cytoprotective effects of miR-140-3p-overexpression were hindered by the co-overexpression of KCNQ1OT1. Furthermore, we found a direct interaction between miR-140-3p and the hypoxia-inducible factor-1α (HIF-1α), which was suppressed by the upregulation of KCNQ1OT1 in OGD/R. Our results indicate that KCNQ1OT1 exacerbates cerebral ischemia–reperfusion injury by targeted binding to miR-140-3p, thus interfering its direct interaction with HIF-1α. These data provide novel therapeutic targets in the cerebral ischemic stroke.
Literature
2.
go back to reference Disease, G. B. D., Incidence Injury, and Collaborators Prevalence. 2018. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 392 (10159): 1789–1858. https://doi.org/10.1016/S0140-6736(18)32279-7. Disease, G. B. D., Incidence Injury, and Collaborators Prevalence. 2018. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 392 (10159): 1789–1858. https://​doi.​org/​10.​1016/​S0140-6736(18)32279-7.
3.
go back to reference Esenwa, C.C., and M.S. Elkind. 2016. Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Nature Reviews. Neurology 12 (10): 594–604.CrossRef Esenwa, C.C., and M.S. Elkind. 2016. Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Nature Reviews. Neurology 12 (10): 594–604.CrossRef
4.
go back to reference Wood, H. 2018. Selective neuronal loss could limit penumbral rescue after stroke. Nature Reviews. Neurology 14 (7): 380–381.CrossRef Wood, H. 2018. Selective neuronal loss could limit penumbral rescue after stroke. Nature Reviews. Neurology 14 (7): 380–381.CrossRef
5.
go back to reference Quinn, J.J., and H.Y. Chang. 2016. Unique features of long non-coding RNA biogenesis and function. Nature Reviews. Genetics 17 (1): 47–62.CrossRef Quinn, J.J., and H.Y. Chang. 2016. Unique features of long non-coding RNA biogenesis and function. Nature Reviews. Genetics 17 (1): 47–62.CrossRef
6.
go back to reference Derrien, T., R. Johnson, G. Bussotti, A. Tanzer, S. Djebali, H. Tilgner, G. Guernec, D. Martin, A. Merkel, D.G. Knowles, J. Lagarde, L. Veeravalli, X. Ruan, Y. Ruan, T. Lassmann, P. Carninci, J.B. Brown, L. Lipovich, J.M. Gonzalez, M. Thomas, C.A. Davis, R. Shiekhattar, T.R. Gingeras, T.J. Hubbard, C. Notredame, J. Harrow, and R. Guigo. 2012. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Research 22 (9): 1775–1789.CrossRef Derrien, T., R. Johnson, G. Bussotti, A. Tanzer, S. Djebali, H. Tilgner, G. Guernec, D. Martin, A. Merkel, D.G. Knowles, J. Lagarde, L. Veeravalli, X. Ruan, Y. Ruan, T. Lassmann, P. Carninci, J.B. Brown, L. Lipovich, J.M. Gonzalez, M. Thomas, C.A. Davis, R. Shiekhattar, T.R. Gingeras, T.J. Hubbard, C. Notredame, J. Harrow, and R. Guigo. 2012. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Research 22 (9): 1775–1789.CrossRef
7.
go back to reference Kanduri, C. 2011. Kcnq1ot1: A chromatin regulatory RNA. Seminars in Cell & Developmental Biology 22 (4): 343–350.CrossRef Kanduri, C. 2011. Kcnq1ot1: A chromatin regulatory RNA. Seminars in Cell & Developmental Biology 22 (4): 343–350.CrossRef
8.
go back to reference Vausort, M., D.R. Wagner, and Y. Devaux. 2014. Long noncoding RNAs in patients with acute myocardial infarction. Circulation Research 115 (7): 668–677.CrossRef Vausort, M., D.R. Wagner, and Y. Devaux. 2014. Long noncoding RNAs in patients with acute myocardial infarction. Circulation Research 115 (7): 668–677.CrossRef
10.
go back to reference Cheng, P., P. Lu, J. Guan, Y. Zhou, L. Zou, X. Yi, et al. 2019. LncRNA KCNQ1OT1 controls cell proliferation, differentiation and apoptosis by sponging miR-326 to regulate c-Myc expression in acute myeloid leukemia. Neoplasma: 181215N–181972N. Cheng, P., P. Lu, J. Guan, Y. Zhou, L. Zou, X. Yi, et al. 2019. LncRNA KCNQ1OT1 controls cell proliferation, differentiation and apoptosis by sponging miR-326 to regulate c-Myc expression in acute myeloid leukemia. Neoplasma: 181215N–181972N.
11.
12.
go back to reference Werner, T.R., A.C. Kunze, J. Stenzig, T. Eschenhagen, and M.N. Hirt. 2019. Blockade of miR-140-3p prevents functional deterioration in afterload-enhanced engineered heart tissue. Scientific Reports 9 (1): 11494.CrossRef Werner, T.R., A.C. Kunze, J. Stenzig, T. Eschenhagen, and M.N. Hirt. 2019. Blockade of miR-140-3p prevents functional deterioration in afterload-enhanced engineered heart tissue. Scientific Reports 9 (1): 11494.CrossRef
13.
go back to reference Al-Modawi, R.N., J.E. Brinchmann, and T.A. Karlsen. 2019. Multi-pathway protective effects of microRNAs on human chondrocytes in an in vitro model of osteoarthritis. Molecular Therapy--Nucleic Acids 17: 776–790.CrossRef Al-Modawi, R.N., J.E. Brinchmann, and T.A. Karlsen. 2019. Multi-pathway protective effects of microRNAs on human chondrocytes in an in vitro model of osteoarthritis. Molecular Therapy--Nucleic Acids 17: 776–790.CrossRef
14.
go back to reference Zhao, L., Y. Qi, L. Xu, X. Tao, X. Han, L. Yin, and J. Peng. 2018. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. Redox Biology 15: 284–296.CrossRef Zhao, L., Y. Qi, L. Xu, X. Tao, X. Han, L. Yin, and J. Peng. 2018. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. Redox Biology 15: 284–296.CrossRef
15.
go back to reference Liu, Q., G.Q. Du, Z.T. Zhu, C. Zhang, X.W. Sun, J.J. Liu, et al. 2015. Identification of apoptosis-related microRNAs and their target genes in myocardial infarction post-transplantation with skeletal myoblasts. Journal of Translational Medicine 13: 270.CrossRef Liu, Q., G.Q. Du, Z.T. Zhu, C. Zhang, X.W. Sun, J.J. Liu, et al. 2015. Identification of apoptosis-related microRNAs and their target genes in myocardial infarction post-transplantation with skeletal myoblasts. Journal of Translational Medicine 13: 270.CrossRef
16.
go back to reference Mo, Z.T., Y.Q. Fang, Y.P. He, and S. Zhang. 2012. Beta-asarone protects PC12 cells against OGD/R-induced injury via attenuating Beclin-1-dependent autophagy. Acta Pharmacologica Sinica 33 (6): 737–742.CrossRef Mo, Z.T., Y.Q. Fang, Y.P. He, and S. Zhang. 2012. Beta-asarone protects PC12 cells against OGD/R-induced injury via attenuating Beclin-1-dependent autophagy. Acta Pharmacologica Sinica 33 (6): 737–742.CrossRef
17.
go back to reference Li, C.T., W.P. Zhang, S.H. Fang, Y.B. Lu, L.H. Zhang, L.L. Qi, X.Q. Huang, X.J. Huang, and E.Q. Wei. 2010. Baicalin attenuates oxygen-glucose deprivation-induced injury by inhibiting oxidative stress-mediated 5-lipoxygenase activation in PC12 cells. Acta Pharmacologica Sinica 31 (2): 137–144.CrossRef Li, C.T., W.P. Zhang, S.H. Fang, Y.B. Lu, L.H. Zhang, L.L. Qi, X.Q. Huang, X.J. Huang, and E.Q. Wei. 2010. Baicalin attenuates oxygen-glucose deprivation-induced injury by inhibiting oxidative stress-mediated 5-lipoxygenase activation in PC12 cells. Acta Pharmacologica Sinica 31 (2): 137–144.CrossRef
18.
go back to reference Zhu, J.R., Y.F. Tao, S. Lou, and Z.M. Wu. 2010. Protective effects of ginsenoside Rb(3) on oxygen and glucose deprivation-induced ischemic injury in PC12 cells. Acta Pharmacologica Sinica 31 (3): 273–280.CrossRef Zhu, J.R., Y.F. Tao, S. Lou, and Z.M. Wu. 2010. Protective effects of ginsenoside Rb(3) on oxygen and glucose deprivation-induced ischemic injury in PC12 cells. Acta Pharmacologica Sinica 31 (3): 273–280.CrossRef
19.
go back to reference Greene, L.A., and A.S. Tischler. 1976. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proceedings of the National Academy of Sciences of the United States of America 73 (7): 2424–2428.CrossRef Greene, L.A., and A.S. Tischler. 1976. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proceedings of the National Academy of Sciences of the United States of America 73 (7): 2424–2428.CrossRef
20.
go back to reference Shao, J., C. Miao, Z. Geng, M. Gu, Y. Wu, and Q. Li. 2019. Effect of eNOS on ischemic postconditioning-induced autophagy against ischemia/reperfusion injury in mice. BioMed Research International 2019: 5201014.CrossRef Shao, J., C. Miao, Z. Geng, M. Gu, Y. Wu, and Q. Li. 2019. Effect of eNOS on ischemic postconditioning-induced autophagy against ischemia/reperfusion injury in mice. BioMed Research International 2019: 5201014.CrossRef
21.
go back to reference Sessa, W.C. 2004. eNOS at a glance. Journal of Cell Science 117 (Pt 12): 2427–2429.CrossRef Sessa, W.C. 2004. eNOS at a glance. Journal of Cell Science 117 (Pt 12): 2427–2429.CrossRef
22.
go back to reference Samdani, A.F., T.M. Dawson, and V.L. Dawson. 1997. Nitric oxide synthase in models of focal ischemia. Stroke. 28 (6): 1283–1288.CrossRef Samdani, A.F., T.M. Dawson, and V.L. Dawson. 1997. Nitric oxide synthase in models of focal ischemia. Stroke. 28 (6): 1283–1288.CrossRef
23.
go back to reference Mizuma, A., J.S. You, and M.A. Yenari. 2018. Targeting reperfusion injury in the age of mechanical thrombectomy. Stroke. 49 (7): 1796–1802.CrossRef Mizuma, A., J.S. You, and M.A. Yenari. 2018. Targeting reperfusion injury in the age of mechanical thrombectomy. Stroke. 49 (7): 1796–1802.CrossRef
24.
go back to reference Paraskevopoulou, M.D., G. Georgakilas, N. Kostoulas, M. Reczko, M. Maragkakis, T.M. Dalamagas, and A.G. Hatzigeorgiou. 2013. DIANA-LncBase: Experimentally verified and computationally predicted microRNA targets on long non-coding RNAs. Nucleic Acids Research 41 (Database issue): D239–D245.CrossRef Paraskevopoulou, M.D., G. Georgakilas, N. Kostoulas, M. Reczko, M. Maragkakis, T.M. Dalamagas, and A.G. Hatzigeorgiou. 2013. DIANA-LncBase: Experimentally verified and computationally predicted microRNA targets on long non-coding RNAs. Nucleic Acids Research 41 (Database issue): D239–D245.CrossRef
25.
go back to reference Jude, J.A., M. Dileepan, S. Subramanian, J. Solway, R.J. Panettieri, T.F. Walseth, et al. 2012. miR-140-3p regulation of TNF-alpha-induced CD38 expression in human airway smooth muscle cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 303 (5): L460–L468.CrossRef Jude, J.A., M. Dileepan, S. Subramanian, J. Solway, R.J. Panettieri, T.F. Walseth, et al. 2012. miR-140-3p regulation of TNF-alpha-induced CD38 expression in human airway smooth muscle cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 303 (5): L460–L468.CrossRef
26.
go back to reference Wei, D.Z., C. Lin, Y.Q. Huang, L.P. Wu, and M.Y. Huang. 2017. Ellagic acid promotes ventricular remodeling after acute myocardial infarction by up-regulating miR-140-3p. Biomedicine & Pharmacotherapy 95: 983–989.CrossRef Wei, D.Z., C. Lin, Y.Q. Huang, L.P. Wu, and M.Y. Huang. 2017. Ellagic acid promotes ventricular remodeling after acute myocardial infarction by up-regulating miR-140-3p. Biomedicine & Pharmacotherapy 95: 983–989.CrossRef
27.
go back to reference Jiang, L., H. Zeng, L. Ni, L. Qi, Y. Xu, L. Xia, Y. Yu, B. Liu, H. Yang, H. Hao, and P. Li. 2019. HIF-1alpha preconditioning potentiates antioxidant activity in ischemic injury: The role of sequential administration of dihydrotanshinone I and protocatechuic aldehyde in cardioprotection. Antioxidants & Redox Signaling 31 (3): 227–242.CrossRef Jiang, L., H. Zeng, L. Ni, L. Qi, Y. Xu, L. Xia, Y. Yu, B. Liu, H. Yang, H. Hao, and P. Li. 2019. HIF-1alpha preconditioning potentiates antioxidant activity in ischemic injury: The role of sequential administration of dihydrotanshinone I and protocatechuic aldehyde in cardioprotection. Antioxidants & Redox Signaling 31 (3): 227–242.CrossRef
28.
go back to reference Ziello, J.E., I.S. Jovin, and Y. Huang. 2007. Hypoxia-inducible factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. The Yale Journal of Biology and Medicine 80 (2): 51–60.PubMedPubMedCentral Ziello, J.E., I.S. Jovin, and Y. Huang. 2007. Hypoxia-inducible factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. The Yale Journal of Biology and Medicine 80 (2): 51–60.PubMedPubMedCentral
29.
go back to reference Stoll, G., and B. Nieswandt. 2019. Thrombo-inflammation in acute ischaemic stroke - implications for treatment. Nature Reviews. Neurology 15 (8): 473–481.CrossRef Stoll, G., and B. Nieswandt. 2019. Thrombo-inflammation in acute ischaemic stroke - implications for treatment. Nature Reviews. Neurology 15 (8): 473–481.CrossRef
30.
go back to reference Inohara, N., and G. Nunez. 2003. NODs: Intracellular proteins involved in inflammation and apoptosis. Nature Reviews. Immunology 3 (5): 371–382.CrossRef Inohara, N., and G. Nunez. 2003. NODs: Intracellular proteins involved in inflammation and apoptosis. Nature Reviews. Immunology 3 (5): 371–382.CrossRef
31.
go back to reference Andersen, J.K. 2004. Oxidative stress in neurodegeneration: Cause or consequence? Nature Medicine 10 (Suppl): S18–S25.CrossRef Andersen, J.K. 2004. Oxidative stress in neurodegeneration: Cause or consequence? Nature Medicine 10 (Suppl): S18–S25.CrossRef
32.
go back to reference Flemming, A. 2019. Calming inflammation to prevent stroke damage. Nature Reviews. Immunology 19 (8): 473.CrossRef Flemming, A. 2019. Calming inflammation to prevent stroke damage. Nature Reviews. Immunology 19 (8): 473.CrossRef
33.
go back to reference Liu, Q., E.M. Johnson, R.K. Lam, Q. Wang, Y.H. Bo, E.N. Wilson, et al. 2019. Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity. Nature Immunology 20 (8): 1023–1034.CrossRef Liu, Q., E.M. Johnson, R.K. Lam, Q. Wang, Y.H. Bo, E.N. Wilson, et al. 2019. Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity. Nature Immunology 20 (8): 1023–1034.CrossRef
34.
go back to reference Zhang, Y., L. Zhang, Y. Wang, H. Ding, S. Xue, H. Yu, L. Hu, H. Qi, Y. Wang, W. Zhu, D. Liu, and P. Li. 2019. KCNQ1OT1, HIF1A-AS2 and APOA1-AS are promising novel biomarkers for diagnosis of coronary artery disease. Clinical and Experimental Pharmacology & Physiology 46 (7): 635–642.CrossRef Zhang, Y., L. Zhang, Y. Wang, H. Ding, S. Xue, H. Yu, L. Hu, H. Qi, Y. Wang, W. Zhu, D. Liu, and P. Li. 2019. KCNQ1OT1, HIF1A-AS2 and APOA1-AS are promising novel biomarkers for diagnosis of coronary artery disease. Clinical and Experimental Pharmacology & Physiology 46 (7): 635–642.CrossRef
35.
go back to reference Li, X., Y. Dai, S. Yan, Y. Shi, B. Han, J. Li, L. Cha, and J. Mu. 2017. Down-regulation of lncRNA KCNQ1OT1 protects against myocardial ischemia/reperfusion injury following acute myocardial infarction. Biochemical and Biophysical Research Communications 491 (4): 1026–1033.CrossRef Li, X., Y. Dai, S. Yan, Y. Shi, B. Han, J. Li, L. Cha, and J. Mu. 2017. Down-regulation of lncRNA KCNQ1OT1 protects against myocardial ischemia/reperfusion injury following acute myocardial infarction. Biochemical and Biophysical Research Communications 491 (4): 1026–1033.CrossRef
36.
go back to reference Wang, D., H. Wang, C. Liu, X. Mu, and S. Cheng. 2019. Hyperglycemia inhibition of endothelial miR-140-3p mediates angiogenic dysfunction in diabetes mellitus. Journal of Diabetes and its Complications 33 (5): 374–382.CrossRef Wang, D., H. Wang, C. Liu, X. Mu, and S. Cheng. 2019. Hyperglycemia inhibition of endothelial miR-140-3p mediates angiogenic dysfunction in diabetes mellitus. Journal of Diabetes and its Complications 33 (5): 374–382.CrossRef
37.
go back to reference Grigelioniene, G., H.I. Suzuki, F. Taylan, F. Mirzamohammadi, Z.U. Borochowitz, U.M. Ayturk, S. Tzur, E. Horemuzova, A. Lindstrand, M.A. Weis, G. Grigelionis, A. Hammarsjö, E. Marsk, A. Nordgren, M. Nordenskjöld, D.R. Eyre, M.L. Warman, G. Nishimura, P.A. Sharp, and T. Kobayashi. 2019. Gain-of-function mutation of microRNA-140 in human skeletal dysplasia. Nature Medicine 25 (4): 583–590.CrossRef Grigelioniene, G., H.I. Suzuki, F. Taylan, F. Mirzamohammadi, Z.U. Borochowitz, U.M. Ayturk, S. Tzur, E. Horemuzova, A. Lindstrand, M.A. Weis, G. Grigelionis, A. Hammarsjö, E. Marsk, A. Nordgren, M. Nordenskjöld, D.R. Eyre, M.L. Warman, G. Nishimura, P.A. Sharp, and T. Kobayashi. 2019. Gain-of-function mutation of microRNA-140 in human skeletal dysplasia. Nature Medicine 25 (4): 583–590.CrossRef
38.
go back to reference Smieszek, A., K. Kornicka, J. Szlapka-Kosarzewska, P. Androvic, L. Valihrach, L. Langerova, E. Rohlova, M. Kubista, and K. Marycz. 2019. Metformin increases proliferative activity and viability of multipotent stromal stem cells isolated from adipose tissue derived from horses with equine metabolic syndrome. Cells 8 (2). https://doi.org/10.3390/cells8020080. Smieszek, A., K. Kornicka, J. Szlapka-Kosarzewska, P. Androvic, L. Valihrach, L. Langerova, E. Rohlova, M. Kubista, and K. Marycz. 2019. Metformin increases proliferative activity and viability of multipotent stromal stem cells isolated from adipose tissue derived from horses with equine metabolic syndrome. Cells 8 (2). https://​doi.​org/​10.​3390/​cells8020080.
39.
go back to reference Zhang, J., J. Yin, X. Chen, X. Mao, J. Xu, R. Cheng, and J. Wu. 2019. Down-regulation of miR-140-3p can alleviate neonatal repetitive pain in rats via inhibiting TGF-beta3. Biochemical and Biophysical Research Communications 515 (4): 627–635.CrossRef Zhang, J., J. Yin, X. Chen, X. Mao, J. Xu, R. Cheng, and J. Wu. 2019. Down-regulation of miR-140-3p can alleviate neonatal repetitive pain in rats via inhibiting TGF-beta3. Biochemical and Biophysical Research Communications 515 (4): 627–635.CrossRef
40.
go back to reference Zhu, Z.R., Q. He, W.B. Wu, G.Q. Chang, C. Yao, Y. Zhao, M. Wang, and S.M. Wang. 2018. MiR-140-3p is involved in in-stent restenosis by targeting C-Myb and BCL-2 in peripheral artery disease. Journal of Atherosclerosis and Thrombosis 25 (11): 1168–1181.CrossRef Zhu, Z.R., Q. He, W.B. Wu, G.Q. Chang, C. Yao, Y. Zhao, M. Wang, and S.M. Wang. 2018. MiR-140-3p is involved in in-stent restenosis by targeting C-Myb and BCL-2 in peripheral artery disease. Journal of Atherosclerosis and Thrombosis 25 (11): 1168–1181.CrossRef
41.
go back to reference Sarkar, S., D. Chakraborty, A. Bhowmik, and M.K. Ghosh. 2019. Cerebral ischemic stroke: cellular fate and therapeutic opportunities. Front Biosci (Landmark Ed). 24: 435–450.CrossRef Sarkar, S., D. Chakraborty, A. Bhowmik, and M.K. Ghosh. 2019. Cerebral ischemic stroke: cellular fate and therapeutic opportunities. Front Biosci (Landmark Ed). 24: 435–450.CrossRef
42.
go back to reference Howell, N.J., and D.A. Tennant. 2014. The role of HIFs in ischemia-reperfusion injury. Hypoxia (Auckl) 2: 107–115. Howell, N.J., and D.A. Tennant. 2014. The role of HIFs in ischemia-reperfusion injury. Hypoxia (Auckl) 2: 107–115.
43.
go back to reference Shi, H. 2009. Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. Current Medicinal Chemistry 16 (34): 4593–4600.CrossRef Shi, H. 2009. Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. Current Medicinal Chemistry 16 (34): 4593–4600.CrossRef
44.
go back to reference Song, J., Y.H. Kang, S. Yoon, C.H. Chun, and E.J. Jin. 2017. HIF-1alpha:CRAT:miR-144-3p axis dysregulation promotes osteoarthritis chondrocyte apoptosis and VLCFA accumulation. Oncotarget. 8 (41): 69351–69361.CrossRef Song, J., Y.H. Kang, S. Yoon, C.H. Chun, and E.J. Jin. 2017. HIF-1alpha:CRAT:miR-144-3p axis dysregulation promotes osteoarthritis chondrocyte apoptosis and VLCFA accumulation. Oncotarget. 8 (41): 69351–69361.CrossRef
45.
go back to reference Ma, Q. 2013. Role of nrf2 in oxidative stress and toxicity. Annual Review of Pharmacology and Toxicology 53: 401–426.CrossRef Ma, Q. 2013. Role of nrf2 in oxidative stress and toxicity. Annual Review of Pharmacology and Toxicology 53: 401–426.CrossRef
Metadata
Title
KCNQ1OT1 Exacerbates Ischemia–Reperfusion Injury Through Targeted Inhibition of miR-140-3P
Authors
Ming Yi
Yue Li
Dan Wang
Qiuxia Zhang
Li Yang
Chunsheng Yang
Publication date
01-10-2020
Publisher
Springer US
Keyword
Stroke
Published in
Inflammation / Issue 5/2020
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-020-01257-2

Other articles of this Issue 5/2020

Inflammation 5/2020 Go to the issue